Altered glial glutamate transporter expression in descending circuitry and the emergence of pain chronicity
PublisherSAGE Publications Inc.
MetadataShow full item record
AbstractBackground: The glutamate type 1 transporter (GLT1) plays a major role in glutamate homeostasis in the brain. Although alterations of GLT1 activity have been linked to persistent pain, the significance of these changes is poorly understood. Focusing on the rostral ventromedial medulla, a key site in pain modulation, we examined the expression and function of GLT1 and related transcription factor kappa B-motif binding phosphoprotein (KBBP) in rats after adjuvant-induced hind paw inflammation. Results: After inflammation, GLT1 and KBBP showed an early upregulation and gradual transition to downregulation that lasted throughout the eight-week observation period. Nitration of GLT1 was reduced at 30 min and increased at eight weeks after inflammation, suggesting an initial increase and later decrease in transporter activity. Mechanical hyperalgesia and paw edema exhibited an initial developing phase with peak hyperalgesia at 4 to 24 h, a subsequent attenuating phase, followed by a late persistent phase that lasted for months. The downregulation of GLT1 occurred at a time when hyperalgesia transitioned into the persistent phase. In the rostral ventromedial medulla, pharmacological block with dihydrokainic acid and RNAi of GLT1 and KBBP increased nociception and overexpression of GLT1 reversed persistent hyperalgesia. Further, the initial upregulation of GLT1 and KBBP was blocked by local anesthetic block, and pretreatment with dihydrokainic acid facilitated the development of hyperalgesia. Conclusions: These results suggest that the initial increased GLT1 activity depends on injury input and serves to dampen the development of hyperalgesia. However, later downregulation of GLT1 fosters the net descending facilitation as injury persists, leading to the emergence of persistent pain. Copyright The Author(s) 2019.
SponsorsThe author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (NS060735 and DE025137 to KR, DE018573 to FW, and DE021804 to RD). MW was supported by Grant-in-Aid for Scientific Research (No. 22592039) from the Japanese Ministry of Education, Science and Culture. JW was supported by the National Natural Science Foundation of China (No. 81371230).
kappa B-motif binding phosphoprotein
rostral ventromedial medulla
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85060737292&doi=10.1177%2f1744806918825044&partnerID=40&md5=c314e87bbce6ded4040dce02b821eca9; http://hdl.handle.net/10713/8651
- The Glt1 glutamate receptor mediates the establishment and perpetuation of chronic visceral pain in an animal model of stress-induced bladder hyperalgesia.
- Authors: Ackerman AL, Jellison FC, Lee UJ, Bradesi S, Rodríguez LV
- Issue date: 2016 Apr 1
- Corticotropin-Releasing Factor in the Brain and Blocking Spinal Descending Signals Induce Hyperalgesia in the Latent Sensitization Model of Chronic Pain.
- Authors: Chen W, Taché Y, Marvizón JC
- Issue date: 2018 Jun 15
- Adenosine Monophosphate-activated Protein Kinase Regulates Interleukin-1β Expression and Glial Glutamate Transporter Function in Rodents with Neuropathic Pain.
- Authors: Maixner DW, Yan X, Gao M, Yadav R, Weng HR
- Issue date: 2015 Jun
- Increased neuronal expression of neurokinin-1 receptor and stimulus-evoked internalization of the receptor in the rostral ventromedial medulla of the rat after peripheral inflammatory injury.
- Authors: Hamity MV, Walder RY, Hammond DL
- Issue date: 2014 Sep 1
- Rostral ventromedial medulla μ, but not κ, opioid receptors are involved in electroacupuncture anti-hyperalgesia in an inflammatory pain rat model.
- Authors: Zhang Y, Li A, Lao L, Xin J, Ren K, Berman BM, Zhang RX
- Issue date: 2011 Jun 13